These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32598639)

  • 21. Chronic liver disease in diabetes mellitus.
    Amarapurkar D; Das HS
    Trop Gastroenterol; 2002; 23(1):3-5. PubMed ID: 12170918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population.
    Jung CH; Lee WJ; Hwang JY; Yu JH; Shin MS; Lee MJ; Jang JE; Leem J; Park JY; Kim HK
    Diabet Med; 2013 Apr; 30(4):428-35. PubMed ID: 23278318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
    Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
    J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic‑induced alterations in hepatic glucose and lipid metabolism: The role of type 1 and type 2 diabetes mellitus (Review).
    Jiang S; Young JL; Wang K; Qian Y; Cai L
    Mol Med Rep; 2020 Aug; 22(2):603-611. PubMed ID: 32468027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions.
    Cusi K
    Diabetologia; 2016 Jun; 59(6):1112-20. PubMed ID: 27101131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy.
    Zhou W; Ye S
    Cell Biol Int; 2018 Sep; 42(10):1282-1291. PubMed ID: 29908010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
    Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
    Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease.
    Grancini V; Trombetta M; Lunati ME; Zimbalatti D; Boselli ML; Gatti S; Donato MF; Resi V; D'Ambrosio R; Aghemo A; Pugliese G; Bonadonna RC; Orsi E
    J Hepatol; 2015 Dec; 63(6):1484-90. PubMed ID: 26297917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of diabetes mellitus and impaired glucose tolerance in patients with decompensated cirrhosis being evaluated for liver transplantation: the utility of oral glucose tolerance test.
    Bragança AC; Alvares-da-Silva MR
    Arq Gastroenterol; 2010; 47(1):22-7. PubMed ID: 20520971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2 diabetes mellitus].
    Kim MG; Choi WC
    Korean J Hepatol; 2006 Dec; 12(4):524-9. PubMed ID: 17237630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of liver diseases on the development of type 2 diabetes mellitus.
    Hsieh PS; Hsieh YJ
    World J Gastroenterol; 2011 Dec; 17(48):5240-5. PubMed ID: 22219592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carbohydrate metabolism dysregulation in cirrhosis: pathophysiology, prognostic impact and therapeutic implications].
    Buyse S; Valla D
    Gastroenterol Clin Biol; 2007 Mar; 31(3):266-73. PubMed ID: 17396083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
    Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of diabetes mellitus of patients with chronic liver disease.
    García-Compeán D; González-González JA; Lavalle-González FJ; González-Moreno EI; Maldonado-Garza HJ; Villarreal-Pérez JZ
    Ann Hepatol; 2015; 14(6):780-8. PubMed ID: 26436350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
    Belfort R; Harrison SA; Brown K; Darland C; Finch J; Hardies J; Balas B; Gastaldelli A; Tio F; Pulcini J; Berria R; Ma JZ; Dwivedi S; Havranek R; Fincke C; DeFronzo R; Bannayan GA; Schenker S; Cusi K
    N Engl J Med; 2006 Nov; 355(22):2297-307. PubMed ID: 17135584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus.
    Kimura Y; Hyogo H; Ishitobi T; Nabeshima Y; Arihiro K; Chayama K
    J Gastroenterol Hepatol; 2011 Mar; 26(3):517-22. PubMed ID: 21054523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.
    Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA
    Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.